Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Aisling Capital

Aisling Capital

A venture capital and private equity firm investing in healthcare and biotechnology companies.

Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.

Investments

The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
FinSMEs
September 24, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
By using this site, you agree to our Terms & Conditions.